{"id":"https://openalex.org/W1900202826","doi":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","title":"Voriconazole concentrations and outcome of invasive fungal infections","display_name":"Voriconazole concentrations and outcome of invasive fungal infections","alternate_titles":[],"publication_year":2009,"publication_date":"2009-10-20","ids":{"openalex":"https://openalex.org/W1900202826","doi":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","mag":"1900202826","pmid":"https://pubmed.ncbi.nlm.nih.gov/19845698"},"language":"en","primary_location":{"id":"doi:10.1111/j.1469-0691.2009.02990.x","doi":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","pdf_url":null,"source":{"id":"https://openalex.org/S71414007","display_name":"Clinical Microbiology and Infection","issn_l":"1198-743X","issn":["1198-743X","1469-0691"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Microbiology and Infection","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1900202826"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008349086","display_name":"Spiros Miyakis","orcid":"https://orcid.org/0000-0003-4268-1599","observed_orcids":["https://orcid.org/0000-0003-4268-1599"]},"institutions":[{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S. Miyakis","raw_affiliation_strings":["Department of Microbiology and Infectious Diseases, New South Wales Referral Laboratory for Therapeutic Drug Monitoring, St Vincent's Hospital, Sydney, NSW, Australia","Department of Microbiology and Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Infectious Diseases, New South Wales Referral Laboratory for Therapeutic Drug Monitoring, St Vincent's Hospital, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I4210087284"]},{"raw_affiliation_string":"Department of Microbiology and Infectious Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063456676","display_name":"Sebastiaan J. van Hal","orcid":"https://orcid.org/0000-0001-5852-4155","observed_orcids":["https://orcid.org/0000-0001-5852-4155"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.J. van Hal","raw_affiliation_strings":["Department of Microbiology and Infectious Diseases, Sydney, NSW, Australia","Department of Microbiology and Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Infectious Diseases, Sydney, NSW, Australia","institution_ids":[]},{"raw_affiliation_string":"Department of Microbiology and Infectious Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061090494","display_name":"John E. Ray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"J. Ray","raw_affiliation_strings":["Department of Clinical Pharmacology and Toxicology, New South Wales Referral Laboratory for Therapeutic Drug Monitoring, St Vincent's Hospital, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Toxicology, New South Wales Referral Laboratory for Therapeutic Drug Monitoring, St Vincent's Hospital, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I4210087284"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081955417","display_name":"Deborah J. E. Marriott","orcid":"https://orcid.org/0000-0003-2493-0766","observed_orcids":["https://orcid.org/0000-0003-2493-0766"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"D. Marriott","raw_affiliation_strings":["Department of Microbiology and Infectious Diseases, Sydney, NSW, Australia","Department of Microbiology and Infectious Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Infectious Diseases, Sydney, NSW, Australia","institution_ids":[]},{"raw_affiliation_string":"Department of Microbiology and Infectious Diseases","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5081955417"],"corresponding_institution_ids":[],"apc_list":{"value":3780,"currency":"USD","value_usd":3780},"apc_paid":null,"fwci":6.6948,"has_fulltext":false,"cited_by_count":168,"citation_normalized_percentile":{"value":0.9696425,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"16","issue":"7","first_page":"927","last_page":"933"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":1.0},{"id":"https://openalex.org/keywords/invasive-fungal-infections","display_name":"invasive fungal infections","score":0.9210000038146973},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.996999979019165},{"id":"https://openalex.org/keywords/trough-concentration","display_name":"trough concentration","score":0.7360000014305115},{"id":"https://openalex.org/keywords/antifungal-dosing","display_name":"antifungal dosing","score":0.7459999918937683},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.703000009059906},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7319999933242798},{"id":"https://openalex.org/keywords/steady-state-concentration","display_name":"steady-state concentration","score":0.5329999923706055},{"id":"https://openalex.org/keywords/classification-and-regression-trees","display_name":"classification and regression trees","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.9864813089370728},{"id":"https://openalex.org/C2910800852","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough Concentration","level":3,"score":0.7959142923355103},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.7525803446769714},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7130143642425537},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6367573142051697},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6054810285568237},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.501823902130127},{"id":"https://openalex.org/C31785415","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough level","level":4,"score":0.49130597710609436},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4224802255630493},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.3762698769569397},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.36775532364845276},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.11425715684890747},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.06057491898536682},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.057814985513687134},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007165","descriptor_name":"Immunosuppression Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1469-0691.2009.02990.x","doi":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","pdf_url":null,"source":{"id":"https://openalex.org/S71414007","display_name":"Clinical Microbiology and Infection","issn_l":"1198-743X","issn":["1198-743X","1469-0691"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Microbiology and Infection","raw_type":"journal-article"},{"id":"pmid:19845698","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19845698","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","raw_type":"Journal Article"},{"id":"pmh:oai:ro.uow.edu.au:medpapers-1556","doi":null,"is_oa":false,"landing_page_url":"https://ro.uow.edu.au/medpapers/552","pdf_url":null,"source":{"id":"https://openalex.org/S4306400510","display_name":"Research Online (University of Wollongong)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204824540","host_organization_name":"University of Wollongong","host_organization_lineage":["https://openalex.org/I204824540"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Graduate School of Medicine - Papers (Archive)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1111/j.1469-0691.2009.02990.x","doi":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1469-0691.2009.02990.x","pdf_url":null,"source":{"id":"https://openalex.org/S71414007","display_name":"Clinical Microbiology and Infection","issn_l":"1198-743X","issn":["1198-743X","1469-0691"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Microbiology and Infection","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W38637850","https://openalex.org/W1556593209","https://openalex.org/W1964720826","https://openalex.org/W1995236993","https://openalex.org/W2013000822","https://openalex.org/W2068574553","https://openalex.org/W2082695689","https://openalex.org/W2087548480","https://openalex.org/W2090225402","https://openalex.org/W2106962923","https://openalex.org/W2123411810","https://openalex.org/W2133328722","https://openalex.org/W2138433856","https://openalex.org/W2142854079","https://openalex.org/W2146753629","https://openalex.org/W2157364677","https://openalex.org/W2162857158","https://openalex.org/W2167539485","https://openalex.org/W2167898101","https://openalex.org/W2171105924","https://openalex.org/W2486772767"],"related_works":["https://openalex.org/W3153037053","https://openalex.org/W2036323185","https://openalex.org/W3216118294","https://openalex.org/W2128112271","https://openalex.org/W1982799360","https://openalex.org/W3030063791","https://openalex.org/W2561885598","https://openalex.org/W3040766888","https://openalex.org/W2283983404","https://openalex.org/W2088158906"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1900202826","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":21},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":16}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
